MiR-1 Is a Tumor Suppressor in Thyroid Carcinogenesis Targeting CCND2, CXCR4, and SDF-1 alpha


Autoria(s): LEONE, Vincenza; D`ANGELO, Daniela; RUBIO, Ileana; FREITAS, Paula Mussnich de; FEDERICO, Antonella; COLAMAIO, Marianna; PALLANTE, Pierlorenzo; MEDEIROS-NETO, Geraldo; FUSCO, Alfredo
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2011

Resumo

Context: Micro-RNA have emerged as an important class of short endogenous RNA that act as posttranscriptional regulators of gene expression and are constantly deregulated inhumancancer. MiR-1 has been found down-regulated in lung, colon, and prostate cancer. Objectives: In this study, we investigated the possible role of miR-1 in thyroid carcinogenesis. Design: We have analyzed miR-1 expression in a panel of thyroid neoplasias including benign and malignant lesions and searched for miR-1 targets. Results: Our results show that miR-1 expression is drastically down-regulated in thyroid adenomas and carcinomas in comparison with normal thyroid tissue. Interestingly, miR-1 down-regulation was also found in thyroid hyperproliferative nonneoplastic lesions such as goiters. We identified the CCND2, coding for the cyclin D2 (CCND2) protein that favors the G1/S transition, CXCR4, and SDF-1 alpha genes, coding for the receptor for the stromal cell derived factor-1 (SDF-1)/CXCL12 chemokine and its ligand SDF-1/CXCL12, respectively, as miR-1 targets. An inverse correlation was found between miR-1 expression and CXC chemokine receptor 4 (CXCR4) and SDF-1 alpha protein levels in papillary and anaplastic thyroid carcinomas. Consistent with a role of the CCND2 protein in cell proliferation and CXCR4 and SDF-1 alpha proteins in cell invasion and metastasis, functional studies demonstrate that miR-1 is able to inhibit thyroid carcinoma cell proliferation and migration. Conclusions: These results indicate the involvement of miR-1 in thyroid cell proliferation and migration, validating a role of miR-1 down-regulation in thyroid carcinogenesis. (J Clin Endocrinol Metab 96: E1388-E1398, 2011)

Associazione Italiana per la Ricerca sul Cancro

Identificador

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, v.96, n.9, p.E1388-E1398, 2011

0021-972X

http://producao.usp.br/handle/BDPI/21668

10.1210/jc.2011-0345

http://dx.doi.org/10.1210/jc.2011-0345

Idioma(s)

eng

Publicador

ENDOCRINE SOC

Relação

Journal of Clinical Endocrinology & Metabolism

Direitos

restrictedAccess

Copyright ENDOCRINE SOC

Palavras-Chave #CHEMOKINE RECEPTOR CXCR4 #CANCER CELLS #PAPILLARY CARCINOMAS #EXPRESSION #MICRORNAS #METASTASIS #GENE #BIOGENESIS #ONCOGENES #FACTOR-1 #Endocrinology & Metabolism
Tipo

article

original article

publishedVersion